The institutes will lead a consortium of researchers investigating the molecular underpinnings of diabetic retinopathy, a key cause of blindness.
The firm's assay is designed to detect the relative abundance of bacteria species in a patient's sample, allowing doctors to improve long-term inpatient care decisions.
Armonica Technologies is looking to develop a nanochannel-based sequencing device that uses optical detection.
In Science this week: convergent evolution in bird hemoglobin, and more.
The technique will use optical maps and barcodes in order to generate long scaffolds from short-read sequencing technology.
The funding will support work identifying the mechanisms underlying the differential responses among pediatric and adult ALL patients to therapy.
NEW YORK (GenomeWeb News) – Life Technologies has added 11 new members from the US and Canada to its Ion AmpliSeq Exome Certified Service Provider program, the company said today.
This story was originally published on Sept. 21.
An international research team genotyped more than 2,000 cervical cancers in New Mexico and investigated how different HPV genotype patterns were linked to cervical cancers, age of diagnosis, and more.
Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.
Retraction Watch's Ivan Oransky and Adam Marcus report that Harvard Medical School and Brigham and Women's Hospital have recommended that more than 30 papers from a former researcher be retracted.
Thomas Steitz, who won the 2009 chemistry Nobel Prize for his ribosome work, has died, the Washington Post reports.
In PLOS this week: mechanisms for genes implicated in coronary artery disease, rumen microbes and host genetics influence cow methane production, and more.